JPMorgan analyst Jeffrey Zekauskas lowered the firm’s price target on Mosaic to $60 from $75 and keeps an Overweight rating on the shares. The analyst reduced the firm’s assessment of normalized EBITDA from $3.5B to $3B to reflect more conservative potash volume and margin assessments and to attribute greater value to the phosphate business. Mosaic’s earnings are coming off the peaks, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOS: